What's happening
This bill expands the definition of drug adulterant testing supplies to include tests for xylazine and other substances, not just fentanyl.
Why it matters
Broader access to drug checking tools. By expanding the definition beyond fentanyl to include xylazine and other substances, the law allows health providers and harm reduction programs to distribute test kits for a wider range of dangerous adulterants, potentially reducing unintentional poisonings.
Responds to evolving drug threats. As xylazine and various novel adulterants increasingly appear in street drug supplies, this change helps public health responses keep pace with emerging risks, rather than being limited to known threats like fentanyl.
Supports harm reduction efforts. Making it legal and explicit to distribute test supplies for more substances may enable more comprehensive education and outreach, empowering drug users with better information to make safer choices and possibly reducing overdose deaths.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Allow Drug Test Kit Dispensing
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 34
History
- Substituted by A8467A
- Advanced to third reading
- 2nd report cal.
- 1st report cal.412
- Print number 7833a
- Amend and recommit to alcoholism and substance use disorders
- Referred to alcoholism and substance use disorders
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Allow Drug Test Kits
Signed by Governor · Sponsor John T. McDonald III
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7833--A
2023-2024 Regular Sessions
IN SENATE
December 20, 2023
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when printed to be committed to the Committee on Rules -- recommitted to the Committee on Alcoholism and Substance Use Disorders in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to the dispensing of drug adulterant testing supplies
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph (a) of subdivision 1 of section 3309-b of the public health law, as amended by chapter 16 of the laws of 2024, is amended to read as follows:
(a) "Drug adulterant testing supplies" means any drug testing product that is used to determine whether a substance contains fentanyl or a fentanyl analog, xylazine, or other substance.
§ 2. This act shall take effect on the thirtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13772-03-4
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to the dispensing of drug adulterant testing supplies
Purpose
Relates to the dispensing of xylazine and other drug adulterant testing supplies by health care professionals or pharmacists
Summary of provisions
Section 1 amends subdivision 1 of section 3309-b of the Public Health Law to add xylazine and other substances to the scope of drug adulterant testing supplies.
Section 2 establishes the effective date.
Justification
In 2023, "Matthew's Law" was chaptered into law and authorized pharma- cists to dispense drug adulterant testing supplies. However, xylazine was not included in the list of drug adulterants.
In 2022, the federal Drug Enforcement Agency issued a report titled "The Growing Threat of Xylazine and its Mixture with Illicit Drugs," and issued a warning to the "American public of a sharp increase in the trafficking of fentanyl mixed with xylazine. Xylazine, also known as "Tram'," is a powerful sedative that the U.S. Food and Drug Adminis- tration has approved for veterinary use...Xylazine is making the deadli- est drug threat our country has ever faced, fentanyl, even deadlier. DEA has seized xylazine and fentanyl mixtures in 48 of 50 States. The DEA Laboratory System is reporting that in 2022 approximately 23% of fenta- nyl powder and 7% of fentanyl pills seized by the DEA contained xyla- zine."
In 2023, New York State began distributing free xylazine test strips, recognizing that xylazine is exacerbating the overdose crisis. Xylazine not only contributes to overdose deaths but also leads to significant skin wounds that can result in amputation along with the risk of seizures. Congress recently passed the bipartisan "Testing, Rapid Analy- sis, and Narcotic Quality (TRANQ) Research Act" that is expected to be signed into law and expanding xylazine testing will further the goals of the TRANQ Act as well.
Legislative history
New bill
Fiscal implications
To be determined.
Effective date
This act shall take effect thirtieth day after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.